Thursday, October 12, 2017

Aerie Pharmaceuticals Inc. (AERI) Leaped To A New High After FDA Review

The FDA posted a preliminary review on its website Wednesday which states that Aerie Pharmaceuticals Inc.'s (AERI) Rhopressa, a treatment for glaucoma, is effective in lowering eye pressure.

from RTT - Before the Bell http://ift.tt/2i9qRg0
via IFTTT

No comments:

Post a Comment